Recruiting

4

24000

RoW

Amlodipine besylate, Amlodipine, Amlodipine besylate And Folic Acid, Amlodipine Folic Acid, Anye, 5-methyltetrahydrofolate (5-MTHF), 5-MTHF, Amlodipine placebo, Amlodipine (dummy), Amlodipine folic acid placebo, Amlodipine folic acid (dummy), 5-MTHF Placebos, 5-MTHF (dummy)

Shenzhen Ausa Pharmed Co.,Ltd, Peking University First Hospital, Second Affiliated Hospital of Nanchang University, The First People's Hospital of Lianyungang, The Affiliated Hospital Of Guizhou Medical University, Lianyungang Oriental Hospital, Tengzhou Central People's Hospital, First Affiliated Hospital Bengbu Medical College, H & J CRO International, Inc., Shenzhen Prospective Medical Technology Co., LTD

Hypertension, MTHFR 677 TT Genotype

06/29

06/29

Recruiting

3

642

RoW

HLX10, Recombinant humanized anti-PD-1 monoclonal antibody injection, Placebos

Shanghai Henlius Biotech

Gastric Cancer

10/23

10/24

Active, not recruiting

3

274

RoW

BPI-16350, placebo, Fulvestrant

Betta Pharmaceuticals Co., Ltd.

Breast Cancer

12/23

07/25

Recruiting

3

688

RoW

Radical colectomy, HIPEC, Systemic chemotherapy

Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Nanfang Hospital of Southern Medical University, Sun Yat-sen University, Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Provincial People's Hospital, Meizhou People's Hospital, First People's Hospital of Foshan, Shantou Central Hospital, Jiangmen Central Hospital, Shenzhen Second People's Hospital, Zhongshan People's Hospital, Guangdong, China, ZhuHai Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Hospital, Beijing Cancer Hospital, Peking University People's Hospital, Fudan University, The Second Affiliated Hospital of Chongqing Medical University, Chongqing University Cancer Hospital, First Affiliated Hospital of Chongqing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Wuhan University, Sichuan Provincial People's Hospital, West China Hospital, The People's Hospital of Leshan, People’s Hospital of Deyang City, Hebei Medical University Fourth Hospital, The First Affiliated Hospital of Nanchang University, The Affiliated Hospital Of Southwest Medical University, The Affiliated Hospital of Xuzhou Medical University, People's Hospital of Guangxi, The Third People's Hospital of Chengdu, The Affiliated Tumor Hospital of Guangxi Medical University

Colorectal Cancer

04/24

04/26

Recruiting

3

918

Europe, Canada, Japan, RoW

Zanidatamab, ZW25, JZP598, Tislelizumab, Trastuzumab, Herceptin®, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil

Jazz Pharmaceuticals, BeiGene, Ltd.

Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma

05/25

05/26

Completed

3

264

Europe, Japan, US, RoW

Depemokimab (GSK3511294), Placebo

GlaxoSmithKline

Nasal Polyps

07/24

08/24

Recruiting

2

90

RoW

Capecitabine, oxaliplatin, Disitamab Vedotin, RC48, Toripalimab, JS001

RemeGen Co., Ltd.

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

01/25

12/27

Recruiting

2

10

RoW

Radiotherapy, PD-1 inhibitor, Neoantigen-loaded DC vaccine

The First Affiliated Hospital of Nanchang University, The First Hospital of Nanchang

Advanced NSCLC

03/26

06/26

Recruiting

1/2

200

RoW

PM1032 injection, PM1032

Biotheus Inc.

Advanced Tumor

04/25

12/25

Recruiting

1

99

RoW

HMPL-A83 injection, HMPL-A83

Hutchmed

Advanced Tumors

06/25

09/25

Recruiting

1

30

RoW

Pressurized Intraperitoneal Aerosol Chemotherapy, Systemic chemotherapy

Guangdong Provincial People's Hospital, Tianjin Third Central Hospital, Peking University Cancer Hospital & Institute, Second Affiliated Hospital of Guangzhou Medical University, The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Henan Cancer Hospital, Tongji Hospital, Wuhan Union Hospital, China, Jiangxi Provincial Cancer Hospital, Xijing Hospital of Air Force Military Medical University, Nanfang Hospital, Southern Medical University, Southern Medical University, China, Affiliated Hospital of Qinghai University, Ruijin Hospital, Shenzhen Second People's Hospital, West China Hospital, Tianjin Nankai Hospital, Yijishan Hospital of Wannan Medical College, Second Affiliated Hospital of Wenzhou Medical University, Changzhi People's Hospital, First Hospital of China Medical University, Xiangya Hospital of Central South University, Sixth Affiliated Hospital, Sun Yat-sen University, Sun Yat-sen University, Fujian Medical University Union Hospital

Peritoneal Carcinoma Metastatic

09/26

09/26

Terminated

1

20

RoW

ABM-1310

ABM Therapeutics Shanghai Company Limited

Advanced Solid Tumor, BRAF V600 Mutation

06/24

06/24

Recruiting

N/A

166

RoW

Laparoscopic D2 distal gastrectomy

West China Hospital, Peking University Cancer Hospital & Institute, Southern Medical University, China, Shanghai Zhongshan Hospital, Chinese PLA General Hospital, Fujian Medical University Union Hospital, Ruijin Hospital, Southwest Hospital, China, RenJi Hospital, The First Affiliated Hospital with Nanjing Medical University, Fudan University, Tang-Du Hospital, Harbin Medical University, The First Hospital of Jilin University, Guangdong Provincial People's Hospital, Sir Run Run Shaw Hospital

Complications, Postoperative, Surgery--Complications, Cancer of Stomach, Chemotherapy Effect

04/20

04/23

Recruiting

N/A

350

RoW

Nutrition Emulsion (TPF-T), Foods for special medical purposes [FSMP] for patients with tumors

Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd

Gastrointestinal Cancer

03/25

03/25

Recruiting

N/A

10

RoW

Radiotherapy, PD-1 inhibitor, Neoantigen-loaded DC vaccine

The First Affiliated Hospital of Nanchang University, The First Hospital of Nanchang

Advanced NSCLC

08/26

02/27

Recruiting

N/A

10

RoW

Radiotherapy, PD-1 inhibitor, Neoantigen-based peptide vaccine

The First Affiliated Hospital of Nanchang University, The First Hospital of Nanchang

Advanced NSCLC

08/26

02/27

Recruiting

N/A

10

RoW

Conventional third-line therapy, Neoantigen-loaded DC vaccine

The First Affiliated Hospital of Nanchang University, The First Hospital of Nanchang

Colorectal Cancer (CRC)

08/26

02/27

Recruiting

N/A

968

RoW

Preoperative staging——D2 gastrectomy——Postoperative staging

Peking University, RenJi Hospital, Ruijin Hospital, West China Hospital, Beijing 302 Hospital, Fudan University, Peking University International Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine, Fujian Medical University Union Hospital, First Affiliated Hospital Xi'an Jiaotong University, Chinese PLA General Hospital, First Affiliated Hospital of Xinjiang Medical University, Tianjin Medical University General Hospital, The Second Affiliated Hospital of Dalian Medical University, Wuhan Union Hospital, China, Peking University People's Hospital, Weifang People's Hospital, Second Hospital of Jilin University, Fujian Province Tumor Hospital, Shanxi Province Cancer Hospital, The First Affiliated Hospital of Nanchang University, Tianjin Medical University Cancer Institute and Hospital, Shanghai Zhongshan Hospital, First Affiliated Hospital, Sun Yat-Sen University, The Affiliated Hospital of Qingdao University, The First Affiliated Hospital of Xiamen University, Beijing Hospital, Beijing Friendship Hospital, Qingdao Municipal Hospital, Guangdong Provincial People's Hospital, Affiliated Hospital of Qinghai University, Shandong Provincial Hospital, First Hospital of Jilin University, Nanfang Hospital of Southern Medical University, Zhongshan Hospital Xiamen University, Hebei Medical University Fourth Hospital

Gastric Cancer, Gastric Cancer Stage, CT, Neoadjuvant Therapy

04/22

10/22